» Articles » PMID: 18406353

Downregulation of CCND1 and CDK6 by MiR-34a Induces Cell Cycle Arrest

Overview
Journal FEBS Lett
Specialty Biochemistry
Date 2008 Apr 15
PMID 18406353
Citations 244
Authors
Affiliations
Soon will be listed here.
Abstract

miRNAs regulate gene expression by inhibiting translation or by targeting messenger RNA (mRNA) for degradation in a post-transcriptional fashion. In the present study, we show that ectopic expression of miR-34a reduces both mRNA and protein levels of cyclin D1 (CCND1) and cyclin-dependent kinase 6 (CDK6). We also demonstrate that miR-34a targets the 3'-untranslated mRNA region of CCND1 as well as CDK6, which in turn interferes with phosphorylation of retinoblastoma. In addition, we show that overexpression of miR-34a induces a significant G1 cell-cycle arrest in the A549 cell line. Taken together, our data suggest that the effects of miR-34a on G1 cell cycle arrest are through the down-regulation of CCND1 and CDK6, which is associated with other targets of miR-34a either additively or synergistically.

Citing Articles

Fungal protein D1 inhibits the proliferation of A549 cells via activating the p53/miR-34a signaling pathway.

Zhang M, Liu F, Gao W, Liu Z J Nat Med. 2025; .

PMID: 39966243 DOI: 10.1007/s11418-024-01869-0.


Identification of molecular subtypes, prognostic status and immunotherapy response in cervical cancer based on angiogenic signature genes.

Deng Z, Zhang L, Sun C, Liu Y, Li B Heliyon. 2024; 10(19):e38488.

PMID: 39391470 PMC: 11466623. DOI: 10.1016/j.heliyon.2024.e38488.


Knockouts of , , or from cholesterol synthesis reveal pathways modulated by sterol intermediates.

Skubic C, Trcek H, Nassib P, Kreft T, Walakira A, Pohar K iScience. 2024; 27(9):110651.

PMID: 39262789 PMC: 11387598. DOI: 10.1016/j.isci.2024.110651.


LincRNA-EPS Promotes Proliferation of Aged Dermal Fibroblast by Inducing CCND1.

Zhang L, Wang I, Meng S, Xu J Int J Mol Sci. 2024; 25(14).

PMID: 39062918 PMC: 11276818. DOI: 10.3390/ijms25147677.


The potential of miRNA-based approaches in glioblastoma: An update in current advances and future perspectives.

Ordonez-Rubiano E, Rincon-Arias N, Espinosa S, Shelton W, Salazar A, Combita A Curr Res Pharmacol Drug Discov. 2024; 7:100193.

PMID: 39055532 PMC: 11268206. DOI: 10.1016/j.crphar.2024.100193.